[{"Assets_0_Q1_USD":4435398000.0,"CommonStockSharesConverted_0_Q1_shares":179033104.0,"CommonStockSharesOutstanding_0_Q1_shares":179033104.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":-54868000.0,"NetIncomeLossConverted_1_Q1_USD":-56473000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":178271000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":178271000.0,"StockholdersEquity_0_Q1_USD":2936627000.0,"EarningsPerShareBasic_1_Q1_USD":-0.32,"EarningsPerShareDiluted_1_Q1_USD":-0.32,"RevenuesConverted_1_Q1_USD":400745000.0,"Ticker":"BMRN","CIK":"1048477","name":"BIOMARIN PHARMACEUTICAL INC","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"14899091235.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190429"}]